nodes	percent_of_prediction	percent_of_DWPC	metapath
Tramadol—restless legs syndrome—Pregabalin—epilepsy syndrome	0.105	0.315	CpDpCtD
Tramadol—restless legs syndrome—Carbamazepine—epilepsy syndrome	0.0939	0.28	CpDpCtD
Tramadol—OPRD1—epilepsy syndrome	0.0779	0.3	CbGaD
Tramadol—restless legs syndrome—Clonazepam—epilepsy syndrome	0.0751	0.224	CpDpCtD
Tramadol—GRIN3A—Felbamate—epilepsy syndrome	0.0728	0.337	CbGbCtD
Tramadol—CHRM3—epilepsy syndrome	0.0662	0.255	CbGaD
Tramadol—restless legs syndrome—Gabapentin—epilepsy syndrome	0.0605	0.181	CpDpCtD
Tramadol—OPRM1—epilepsy syndrome	0.0596	0.23	CbGaD
Tramadol—SLC6A4—epilepsy syndrome	0.0328	0.126	CbGaD
Tramadol—CYP2D6—epilepsy syndrome	0.0231	0.0889	CbGaD
Tramadol—CYP2B6—Fosphenytoin—epilepsy syndrome	0.0131	0.0608	CbGbCtD
Tramadol—CYP2B6—Clobazam—epilepsy syndrome	0.0114	0.0527	CbGbCtD
Tramadol—CYP2B6—Carbamazepine—epilepsy syndrome	0.00945	0.0437	CbGbCtD
Tramadol—CYP2B6—Primidone—epilepsy syndrome	0.00882	0.0408	CbGbCtD
Tramadol—CYP2B6—Phenytoin—epilepsy syndrome	0.00847	0.0392	CbGbCtD
Tramadol—CYP2B6—Propofol—epilepsy syndrome	0.0079	0.0365	CbGbCtD
Tramadol—CYP2B6—Phenobarbital—epilepsy syndrome	0.00755	0.0349	CbGbCtD
Tramadol—CYP2B6—Midazolam—epilepsy syndrome	0.00745	0.0344	CbGbCtD
Tramadol—CYP2B6—Diazepam—epilepsy syndrome	0.00716	0.0331	CbGbCtD
Tramadol—CYP2B6—Valproic Acid—epilepsy syndrome	0.00564	0.0261	CbGbCtD
Tramadol—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00462	0.0214	CbGbCtD
Tramadol—CYP3A4—Felbamate—epilepsy syndrome	0.0043	0.0199	CbGbCtD
Tramadol—CYP3A4—Trimethadione—epilepsy syndrome	0.0043	0.0199	CbGbCtD
Tramadol—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00404	0.0187	CbGbCtD
Tramadol—CYP2D6—Propofol—epilepsy syndrome	0.00382	0.0177	CbGbCtD
Tramadol—CYP3A4—Clonazepam—epilepsy syndrome	0.00365	0.0169	CbGbCtD
Tramadol—CYP3A4—Clobazam—epilepsy syndrome	0.0035	0.0162	CbGbCtD
Tramadol—CYP3A4—Rufinamide—epilepsy syndrome	0.00298	0.0138	CbGbCtD
Tramadol—CYP3A4—Carbamazepine—epilepsy syndrome	0.0029	0.0134	CbGbCtD
Tramadol—CYP3A4—Primidone—epilepsy syndrome	0.00271	0.0125	CbGbCtD
Tramadol—CYP3A4—Phenytoin—epilepsy syndrome	0.0026	0.012	CbGbCtD
Tramadol—CYP3A4—Propofol—epilepsy syndrome	0.00243	0.0112	CbGbCtD
Tramadol—CYP3A4—Acetazolamide—epilepsy syndrome	0.00232	0.0107	CbGbCtD
Tramadol—CYP3A4—Phenobarbital—epilepsy syndrome	0.00232	0.0107	CbGbCtD
Tramadol—CYP3A4—Midazolam—epilepsy syndrome	0.00229	0.0106	CbGbCtD
Tramadol—CYP3A4—Diazepam—epilepsy syndrome	0.0022	0.0102	CbGbCtD
Tramadol—CYP3A4—Zonisamide—epilepsy syndrome	0.00215	0.00993	CbGbCtD
Tramadol—SLC6A2—locus ceruleus—epilepsy syndrome	0.00192	0.0759	CbGeAlD
Tramadol—CYP3A4—Valproic Acid—epilepsy syndrome	0.00173	0.00802	CbGbCtD
Tramadol—CYP3A4—Topiramate—epilepsy syndrome	0.00156	0.00723	CbGbCtD
Tramadol—OPRM1—telencephalic ventricle—epilepsy syndrome	0.00124	0.0492	CbGeAlD
Tramadol—OPRD1—ganglion—epilepsy syndrome	0.00113	0.0449	CbGeAlD
Tramadol—HTR2C—telencephalic ventricle—epilepsy syndrome	0.00109	0.0431	CbGeAlD
Tramadol—SLC6A2—autonomic nervous system—epilepsy syndrome	0.00102	0.0403	CbGeAlD
Tramadol—OPRM1—ganglion—epilepsy syndrome	0.000772	0.0306	CbGeAlD
Tramadol—HTR2C—ganglion—epilepsy syndrome	0.000677	0.0268	CbGeAlD
Tramadol—GRIN3A—forebrain—epilepsy syndrome	0.000674	0.0267	CbGeAlD
Tramadol—SLC6A4—ganglion—epilepsy syndrome	0.000642	0.0254	CbGeAlD
Tramadol—GRIN3A—telencephalon—epilepsy syndrome	0.00062	0.0246	CbGeAlD
Tramadol—SLC6A2—ganglion—epilepsy syndrome	0.000565	0.0224	CbGeAlD
Tramadol—SLC6A4—hindbrain—epilepsy syndrome	0.000487	0.0193	CbGeAlD
Tramadol—OPRD1—forebrain—epilepsy syndrome	0.000475	0.0188	CbGeAlD
Tramadol—OPRK1—forebrain—epilepsy syndrome	0.000455	0.018	CbGeAlD
Tramadol—OPRD1—telencephalon—epilepsy syndrome	0.000437	0.0173	CbGeAlD
Tramadol—GRIN3A—head—epilepsy syndrome	0.000386	0.0153	CbGeAlD
Tramadol—GRIN3A—nervous system—epilepsy syndrome	0.000366	0.0145	CbGeAlD
Tramadol—GRIN3A—central nervous system—epilepsy syndrome	0.000352	0.014	CbGeAlD
Tramadol—OPRM1—brainstem—epilepsy syndrome	0.000336	0.0133	CbGeAlD
Tramadol—OPRM1—forebrain—epilepsy syndrome	0.000324	0.0128	CbGeAlD
Tramadol—Dextromethorphan—CHRNA2—epilepsy syndrome	0.000315	0.142	CrCbGaD
Tramadol—Dextromethorphan—CHRNB2—epilepsy syndrome	0.000308	0.139	CrCbGaD
Tramadol—OPRM1—telencephalon—epilepsy syndrome	0.000298	0.0118	CbGeAlD
Tramadol—HTR2C—brainstem—epilepsy syndrome	0.000294	0.0117	CbGeAlD
Tramadol—HTR2C—forebrain—epilepsy syndrome	0.000284	0.0113	CbGeAlD
Tramadol—GRIN3A—brain—epilepsy syndrome	0.00028	0.0111	CbGeAlD
Tramadol—SLC6A4—brainstem—epilepsy syndrome	0.000279	0.0111	CbGeAlD
Tramadol—OPRD1—head—epilepsy syndrome	0.000272	0.0108	CbGeAlD
Tramadol—SLC6A4—forebrain—epilepsy syndrome	0.000269	0.0107	CbGeAlD
Tramadol—HTR2C—telencephalon—epilepsy syndrome	0.000261	0.0104	CbGeAlD
Tramadol—OPRK1—head—epilepsy syndrome	0.000261	0.0103	CbGeAlD
Tramadol—OPRD1—nervous system—epilepsy syndrome	0.000258	0.0102	CbGeAlD
Tramadol—OPRD1—central nervous system—epilepsy syndrome	0.000248	0.00984	CbGeAlD
Tramadol—SLC6A4—telencephalon—epilepsy syndrome	0.000248	0.00982	CbGeAlD
Tramadol—OPRK1—nervous system—epilepsy syndrome	0.000247	0.0098	CbGeAlD
Tramadol—SLC6A2—brainstem—epilepsy syndrome	0.000246	0.00974	CbGeAlD
Tramadol—CHRM3—forebrain—epilepsy syndrome	0.00024	0.00952	CbGeAlD
Tramadol—OPRK1—central nervous system—epilepsy syndrome	0.000238	0.00943	CbGeAlD
Tramadol—SLC6A2—forebrain—epilepsy syndrome	0.000237	0.0094	CbGeAlD
Tramadol—CYP2D6—hindbrain—epilepsy syndrome	0.000235	0.0093	CbGeAlD
Tramadol—OPRK1—cerebellum—epilepsy syndrome	0.000233	0.00922	CbGeAlD
Tramadol—CHRM3—telencephalon—epilepsy syndrome	0.000221	0.00875	CbGeAlD
Tramadol—SLC6A2—telencephalon—epilepsy syndrome	0.000218	0.00864	CbGeAlD
Tramadol—OPRM1—midbrain—epilepsy syndrome	0.000214	0.00848	CbGeAlD
Tramadol—OPRM1—spinal cord—epilepsy syndrome	0.000209	0.00827	CbGeAlD
Tramadol—HTR2C—medulla oblongata—epilepsy syndrome	0.000205	0.00814	CbGeAlD
Tramadol—Venlafaxine—ABCG2—epilepsy syndrome	0.000201	0.091	CrCbGaD
Tramadol—OPRD1—brain—epilepsy syndrome	0.000197	0.00781	CbGeAlD
Tramadol—OPRK1—brain—epilepsy syndrome	0.000189	0.00749	CbGeAlD
Tramadol—HTR2C—midbrain—epilepsy syndrome	0.000188	0.00744	CbGeAlD
Tramadol—OPRM1—head—epilepsy syndrome	0.000185	0.00735	CbGeAlD
Tramadol—HTR2C—spinal cord—epilepsy syndrome	0.000183	0.00726	CbGeAlD
Tramadol—Dextromethorphan—CHRNA7—epilepsy syndrome	0.000181	0.0816	CrCbGaD
Tramadol—SLC6A4—midbrain—epilepsy syndrome	0.000178	0.00705	CbGeAlD
Tramadol—OPRM1—nervous system—epilepsy syndrome	0.000176	0.00697	CbGeAlD
Tramadol—Dextromethorphan—OPRD1—epilepsy syndrome	0.000174	0.0784	CrCbGaD
Tramadol—SLC6A4—spinal cord—epilepsy syndrome	0.000174	0.00688	CbGeAlD
Tramadol—SLC6A2—medulla oblongata—epilepsy syndrome	0.000171	0.00679	CbGeAlD
Tramadol—OPRM1—central nervous system—epilepsy syndrome	0.000169	0.00671	CbGeAlD
Tramadol—Venlafaxine—SLC6A4—epilepsy syndrome	0.000167	0.0755	CrCbGaD
Tramadol—HTR2C—head—epilepsy syndrome	0.000163	0.00645	CbGeAlD
Tramadol—Venlafaxine—CYP2C19—epilepsy syndrome	0.000158	0.0716	CrCbGaD
Tramadol—HTR2C—nervous system—epilepsy syndrome	0.000154	0.00611	CbGeAlD
Tramadol—SLC6A4—head—epilepsy syndrome	0.000154	0.00611	CbGeAlD
Tramadol—HTR2C—central nervous system—epilepsy syndrome	0.000149	0.00589	CbGeAlD
Tramadol—SLC6A4—nervous system—epilepsy syndrome	0.000146	0.0058	CbGeAlD
Tramadol—Dextromethorphan—CHRNA4—epilepsy syndrome	0.000144	0.0653	CrCbGaD
Tramadol—SLC6A4—central nervous system—epilepsy syndrome	0.000141	0.00558	CbGeAlD
Tramadol—CHRM3—head—epilepsy syndrome	0.000137	0.00545	CbGeAlD
Tramadol—SLC6A2—head—epilepsy syndrome	0.000136	0.00538	CbGeAlD
Tramadol—CYP2D6—brainstem—epilepsy syndrome	0.000135	0.00533	CbGeAlD
Tramadol—OPRM1—brain—epilepsy syndrome	0.000134	0.00533	CbGeAlD
Tramadol—Dextromethorphan—OPRM1—epilepsy syndrome	0.000133	0.06	CrCbGaD
Tramadol—CHRM3—nervous system—epilepsy syndrome	0.00013	0.00517	CbGeAlD
Tramadol—CYP2D6—forebrain—epilepsy syndrome	0.00013	0.00515	CbGeAlD
Tramadol—SLC6A2—nervous system—epilepsy syndrome	0.000129	0.0051	CbGeAlD
Tramadol—CHRM3—central nervous system—epilepsy syndrome	0.000126	0.00497	CbGeAlD
Tramadol—SLC6A2—central nervous system—epilepsy syndrome	0.000124	0.00491	CbGeAlD
Tramadol—CYP2D6—telencephalon—epilepsy syndrome	0.000119	0.00473	CbGeAlD
Tramadol—HTR2C—brain—epilepsy syndrome	0.000118	0.00467	CbGeAlD
Tramadol—Venlafaxine—CYP2D6—epilepsy syndrome	0.000117	0.0531	CrCbGaD
Tramadol—SLC6A4—brain—epilepsy syndrome	0.000112	0.00443	CbGeAlD
Tramadol—CYP2B6—head—epilepsy syndrome	0.0001	0.00397	CbGeAlD
Tramadol—CHRM3—brain—epilepsy syndrome	9.96e-05	0.00395	CbGeAlD
Tramadol—SLC6A2—brain—epilepsy syndrome	9.84e-05	0.0039	CbGeAlD
Tramadol—CYP2B6—nervous system—epilepsy syndrome	9.49e-05	0.00376	CbGeAlD
Tramadol—CYP2B6—central nervous system—epilepsy syndrome	9.13e-05	0.00362	CbGeAlD
Tramadol—Venlafaxine—ABCB1—epilepsy syndrome	8.39e-05	0.0379	CrCbGaD
Tramadol—CYP2D6—head—epilepsy syndrome	7.43e-05	0.00295	CbGeAlD
Tramadol—Dextromethorphan—SLC6A4—epilepsy syndrome	7.32e-05	0.0331	CrCbGaD
Tramadol—CYP2B6—brain—epilepsy syndrome	7.25e-05	0.00287	CbGeAlD
Tramadol—CYP3A4—nervous system—epilepsy syndrome	7.16e-05	0.00284	CbGeAlD
Tramadol—CYP2D6—nervous system—epilepsy syndrome	7.05e-05	0.00279	CbGeAlD
Tramadol—Dextromethorphan—CYP2C19—epilepsy syndrome	6.94e-05	0.0313	CrCbGaD
Tramadol—CYP3A4—central nervous system—epilepsy syndrome	6.9e-05	0.00273	CbGeAlD
Tramadol—CYP2D6—central nervous system—epilepsy syndrome	6.79e-05	0.00269	CbGeAlD
Tramadol—CYP2D6—cerebellum—epilepsy syndrome	6.63e-05	0.00263	CbGeAlD
Tramadol—CYP2D6—brain—epilepsy syndrome	5.39e-05	0.00214	CbGeAlD
Tramadol—Dextromethorphan—CYP2D6—epilepsy syndrome	5.14e-05	0.0232	CrCbGaD
Tramadol—Dextromethorphan—ABCB1—epilepsy syndrome	3.67e-05	0.0166	CrCbGaD
Tramadol—Headache—Diazepam—epilepsy syndrome	9.47e-06	8.1e-05	CcSEcCtD
Tramadol—Anxiety—Pregabalin—epilepsy syndrome	9.45e-06	8.08e-05	CcSEcCtD
Tramadol—Diarrhoea—Clonazepam—epilepsy syndrome	9.45e-06	8.08e-05	CcSEcCtD
Tramadol—Anaemia—Gabapentin—epilepsy syndrome	9.44e-06	8.07e-05	CcSEcCtD
Tramadol—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	9.42e-06	8.05e-05	CcSEcCtD
Tramadol—Hypotension—Valproic Acid—epilepsy syndrome	9.4e-06	8.03e-05	CcSEcCtD
Tramadol—Asthenia—Carbamazepine—epilepsy syndrome	9.39e-06	8.03e-05	CcSEcCtD
Tramadol—Agitation—Gabapentin—epilepsy syndrome	9.39e-06	8.02e-05	CcSEcCtD
Tramadol—Diarrhoea—Phenytoin—epilepsy syndrome	9.38e-06	8.02e-05	CcSEcCtD
Tramadol—Discomfort—Pregabalin—epilepsy syndrome	9.37e-06	8.01e-05	CcSEcCtD
Tramadol—Nausea—Fosphenytoin—epilepsy syndrome	9.36e-06	8e-05	CcSEcCtD
Tramadol—Diarrhoea—Oxcarbazepine—epilepsy syndrome	9.34e-06	7.98e-05	CcSEcCtD
Tramadol—Erythema multiforme—Topiramate—epilepsy syndrome	9.33e-06	7.98e-05	CcSEcCtD
Tramadol—Angioedema—Gabapentin—epilepsy syndrome	9.33e-06	7.98e-05	CcSEcCtD
Tramadol—Hypersensitivity—Lamotrigine—epilepsy syndrome	9.32e-06	7.97e-05	CcSEcCtD
Tramadol—Vomiting—Felbamate—epilepsy syndrome	9.31e-06	7.95e-05	CcSEcCtD
Tramadol—Dry mouth—Pregabalin—epilepsy syndrome	9.27e-06	7.93e-05	CcSEcCtD
Tramadol—Pruritus—Carbamazepine—epilepsy syndrome	9.26e-06	7.92e-05	CcSEcCtD
Tramadol—Rash—Felbamate—epilepsy syndrome	9.23e-06	7.89e-05	CcSEcCtD
Tramadol—Eye disorder—Topiramate—epilepsy syndrome	9.22e-06	7.88e-05	CcSEcCtD
Tramadol—Dermatitis—Felbamate—epilepsy syndrome	9.22e-06	7.88e-05	CcSEcCtD
Tramadol—Malaise—Gabapentin—epilepsy syndrome	9.21e-06	7.87e-05	CcSEcCtD
Tramadol—Tinnitus—Topiramate—epilepsy syndrome	9.2e-06	7.87e-05	CcSEcCtD
Tramadol—Vertigo—Gabapentin—epilepsy syndrome	9.18e-06	7.84e-05	CcSEcCtD
Tramadol—Headache—Felbamate—epilepsy syndrome	9.17e-06	7.84e-05	CcSEcCtD
Tramadol—Confusional state—Pregabalin—epilepsy syndrome	9.17e-06	7.83e-05	CcSEcCtD
Tramadol—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	9.16e-06	7.83e-05	CcSEcCtD
Tramadol—Flushing—Topiramate—epilepsy syndrome	9.16e-06	7.83e-05	CcSEcCtD
Tramadol—Cardiac disorder—Topiramate—epilepsy syndrome	9.16e-06	7.83e-05	CcSEcCtD
Tramadol—Syncope—Gabapentin—epilepsy syndrome	9.16e-06	7.83e-05	CcSEcCtD
Tramadol—Dizziness—Clonazepam—epilepsy syndrome	9.13e-06	7.8e-05	CcSEcCtD
Tramadol—Nausea—Vigabatrin—epilepsy syndrome	9.12e-06	7.8e-05	CcSEcCtD
Tramadol—Vomiting—Zonisamide—epilepsy syndrome	9.11e-06	7.79e-05	CcSEcCtD
Tramadol—Insomnia—Valproic Acid—epilepsy syndrome	9.09e-06	7.77e-05	CcSEcCtD
Tramadol—Anaphylactic shock—Pregabalin—epilepsy syndrome	9.09e-06	7.77e-05	CcSEcCtD
Tramadol—Asthenia—Lamotrigine—epilepsy syndrome	9.08e-06	7.76e-05	CcSEcCtD
Tramadol—Dizziness—Phenytoin—epilepsy syndrome	9.07e-06	7.75e-05	CcSEcCtD
Tramadol—Rash—Zonisamide—epilepsy syndrome	9.03e-06	7.72e-05	CcSEcCtD
Tramadol—Infection—Pregabalin—epilepsy syndrome	9.03e-06	7.72e-05	CcSEcCtD
Tramadol—Paraesthesia—Valproic Acid—epilepsy syndrome	9.03e-06	7.72e-05	CcSEcCtD
Tramadol—Palpitations—Gabapentin—epilepsy syndrome	9.03e-06	7.71e-05	CcSEcCtD
Tramadol—Dermatitis—Zonisamide—epilepsy syndrome	9.03e-06	7.71e-05	CcSEcCtD
Tramadol—Dizziness—Oxcarbazepine—epilepsy syndrome	9.02e-06	7.71e-05	CcSEcCtD
Tramadol—Nausea—Diazepam—epilepsy syndrome	8.98e-06	7.68e-05	CcSEcCtD
Tramadol—Loss of consciousness—Gabapentin—epilepsy syndrome	8.98e-06	7.67e-05	CcSEcCtD
Tramadol—Headache—Zonisamide—epilepsy syndrome	8.98e-06	7.67e-05	CcSEcCtD
Tramadol—Dyspnoea—Valproic Acid—epilepsy syndrome	8.96e-06	7.66e-05	CcSEcCtD
Tramadol—Diarrhoea—Carbamazepine—epilepsy syndrome	8.96e-06	7.66e-05	CcSEcCtD
Tramadol—Angiopathy—Topiramate—epilepsy syndrome	8.96e-06	7.65e-05	CcSEcCtD
Tramadol—Pruritus—Lamotrigine—epilepsy syndrome	8.95e-06	7.65e-05	CcSEcCtD
Tramadol—Shock—Pregabalin—epilepsy syndrome	8.94e-06	7.64e-05	CcSEcCtD
Tramadol—Somnolence—Valproic Acid—epilepsy syndrome	8.94e-06	7.64e-05	CcSEcCtD
Tramadol—Immune system disorder—Topiramate—epilepsy syndrome	8.92e-06	7.62e-05	CcSEcCtD
Tramadol—Nervous system disorder—Pregabalin—epilepsy syndrome	8.91e-06	7.62e-05	CcSEcCtD
Tramadol—Cough—Gabapentin—epilepsy syndrome	8.91e-06	7.62e-05	CcSEcCtD
Tramadol—Thrombocytopenia—Pregabalin—epilepsy syndrome	8.9e-06	7.61e-05	CcSEcCtD
Tramadol—Mediastinal disorder—Topiramate—epilepsy syndrome	8.9e-06	7.6e-05	CcSEcCtD
Tramadol—Tachycardia—Pregabalin—epilepsy syndrome	8.87e-06	7.58e-05	CcSEcCtD
Tramadol—Chills—Topiramate—epilepsy syndrome	8.86e-06	7.57e-05	CcSEcCtD
Tramadol—Dyspepsia—Valproic Acid—epilepsy syndrome	8.85e-06	7.56e-05	CcSEcCtD
Tramadol—Convulsion—Gabapentin—epilepsy syndrome	8.85e-06	7.56e-05	CcSEcCtD
Tramadol—Skin disorder—Pregabalin—epilepsy syndrome	8.83e-06	7.55e-05	CcSEcCtD
Tramadol—Hypertension—Gabapentin—epilepsy syndrome	8.82e-06	7.54e-05	CcSEcCtD
Tramadol—Hyperhidrosis—Pregabalin—epilepsy syndrome	8.79e-06	7.51e-05	CcSEcCtD
Tramadol—Vomiting—Clonazepam—epilepsy syndrome	8.78e-06	7.5e-05	CcSEcCtD
Tramadol—Decreased appetite—Valproic Acid—epilepsy syndrome	8.74e-06	7.47e-05	CcSEcCtD
Tramadol—Vomiting—Phenytoin—epilepsy syndrome	8.72e-06	7.45e-05	CcSEcCtD
Tramadol—Rash—Clonazepam—epilepsy syndrome	8.71e-06	7.44e-05	CcSEcCtD
Tramadol—Dermatitis—Clonazepam—epilepsy syndrome	8.7e-06	7.43e-05	CcSEcCtD
Tramadol—Arthralgia—Gabapentin—epilepsy syndrome	8.7e-06	7.43e-05	CcSEcCtD
Tramadol—Chest pain—Gabapentin—epilepsy syndrome	8.7e-06	7.43e-05	CcSEcCtD
Tramadol—Myalgia—Gabapentin—epilepsy syndrome	8.7e-06	7.43e-05	CcSEcCtD
Tramadol—Nausea—Felbamate—epilepsy syndrome	8.69e-06	7.43e-05	CcSEcCtD
Tramadol—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	8.68e-06	7.42e-05	CcSEcCtD
Tramadol—Vomiting—Oxcarbazepine—epilepsy syndrome	8.67e-06	7.41e-05	CcSEcCtD
Tramadol—Fatigue—Valproic Acid—epilepsy syndrome	8.67e-06	7.41e-05	CcSEcCtD
Tramadol—Anxiety—Gabapentin—epilepsy syndrome	8.67e-06	7.41e-05	CcSEcCtD
Tramadol—Anorexia—Pregabalin—epilepsy syndrome	8.66e-06	7.41e-05	CcSEcCtD
Tramadol—Dizziness—Carbamazepine—epilepsy syndrome	8.66e-06	7.4e-05	CcSEcCtD
Tramadol—Diarrhoea—Lamotrigine—epilepsy syndrome	8.66e-06	7.4e-05	CcSEcCtD
Tramadol—Headache—Clonazepam—epilepsy syndrome	8.65e-06	7.39e-05	CcSEcCtD
Tramadol—Rash—Phenytoin—epilepsy syndrome	8.65e-06	7.39e-05	CcSEcCtD
Tramadol—Mental disorder—Topiramate—epilepsy syndrome	8.65e-06	7.39e-05	CcSEcCtD
Tramadol—Dermatitis—Phenytoin—epilepsy syndrome	8.64e-06	7.38e-05	CcSEcCtD
Tramadol—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	8.64e-06	7.38e-05	CcSEcCtD
Tramadol—Rash—Oxcarbazepine—epilepsy syndrome	8.6e-06	7.35e-05	CcSEcCtD
Tramadol—Pain—Valproic Acid—epilepsy syndrome	8.6e-06	7.35e-05	CcSEcCtD
Tramadol—Constipation—Valproic Acid—epilepsy syndrome	8.6e-06	7.35e-05	CcSEcCtD
Tramadol—Dermatitis—Oxcarbazepine—epilepsy syndrome	8.59e-06	7.35e-05	CcSEcCtD
Tramadol—Headache—Phenytoin—epilepsy syndrome	8.59e-06	7.34e-05	CcSEcCtD
Tramadol—Erythema—Topiramate—epilepsy syndrome	8.59e-06	7.34e-05	CcSEcCtD
Tramadol—Malnutrition—Topiramate—epilepsy syndrome	8.59e-06	7.34e-05	CcSEcCtD
Tramadol—Discomfort—Gabapentin—epilepsy syndrome	8.59e-06	7.34e-05	CcSEcCtD
Tramadol—Headache—Oxcarbazepine—epilepsy syndrome	8.55e-06	7.31e-05	CcSEcCtD
Tramadol—Nausea—Zonisamide—epilepsy syndrome	8.51e-06	7.27e-05	CcSEcCtD
Tramadol—Dry mouth—Gabapentin—epilepsy syndrome	8.5e-06	7.27e-05	CcSEcCtD
Tramadol—Hypotension—Pregabalin—epilepsy syndrome	8.49e-06	7.26e-05	CcSEcCtD
Tramadol—Flatulence—Topiramate—epilepsy syndrome	8.47e-06	7.24e-05	CcSEcCtD
Tramadol—Tension—Topiramate—epilepsy syndrome	8.43e-06	7.21e-05	CcSEcCtD
Tramadol—Dysgeusia—Topiramate—epilepsy syndrome	8.41e-06	7.19e-05	CcSEcCtD
Tramadol—Confusional state—Gabapentin—epilepsy syndrome	8.4e-06	7.18e-05	CcSEcCtD
Tramadol—Dizziness—Lamotrigine—epilepsy syndrome	8.37e-06	7.15e-05	CcSEcCtD
Tramadol—Nervousness—Topiramate—epilepsy syndrome	8.35e-06	7.13e-05	CcSEcCtD
Tramadol—Anaphylactic shock—Gabapentin—epilepsy syndrome	8.34e-06	7.12e-05	CcSEcCtD
Tramadol—Vomiting—Carbamazepine—epilepsy syndrome	8.32e-06	7.11e-05	CcSEcCtD
Tramadol—Back pain—Topiramate—epilepsy syndrome	8.31e-06	7.1e-05	CcSEcCtD
Tramadol—Feeling abnormal—Valproic Acid—epilepsy syndrome	8.29e-06	7.08e-05	CcSEcCtD
Tramadol—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	8.28e-06	7.08e-05	CcSEcCtD
Tramadol—Infection—Gabapentin—epilepsy syndrome	8.28e-06	7.08e-05	CcSEcCtD
Tramadol—Muscle spasms—Topiramate—epilepsy syndrome	8.26e-06	7.06e-05	CcSEcCtD
Tramadol—Rash—Carbamazepine—epilepsy syndrome	8.26e-06	7.06e-05	CcSEcCtD
Tramadol—Dermatitis—Carbamazepine—epilepsy syndrome	8.25e-06	7.05e-05	CcSEcCtD
Tramadol—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	8.22e-06	7.03e-05	CcSEcCtD
Tramadol—Insomnia—Pregabalin—epilepsy syndrome	8.22e-06	7.03e-05	CcSEcCtD
Tramadol—Nausea—Clonazepam—epilepsy syndrome	8.2e-06	7.01e-05	CcSEcCtD
Tramadol—Headache—Carbamazepine—epilepsy syndrome	8.2e-06	7.01e-05	CcSEcCtD
Tramadol—Shock—Gabapentin—epilepsy syndrome	8.2e-06	7.01e-05	CcSEcCtD
Tramadol—Nervous system disorder—Gabapentin—epilepsy syndrome	8.17e-06	6.99e-05	CcSEcCtD
Tramadol—Paraesthesia—Pregabalin—epilepsy syndrome	8.16e-06	6.98e-05	CcSEcCtD
Tramadol—Thrombocytopenia—Gabapentin—epilepsy syndrome	8.16e-06	6.98e-05	CcSEcCtD
Tramadol—Nausea—Phenytoin—epilepsy syndrome	8.15e-06	6.96e-05	CcSEcCtD
Tramadol—Tachycardia—Gabapentin—epilepsy syndrome	8.14e-06	6.95e-05	CcSEcCtD
Tramadol—Dyspnoea—Pregabalin—epilepsy syndrome	8.1e-06	6.93e-05	CcSEcCtD
Tramadol—Nausea—Oxcarbazepine—epilepsy syndrome	8.1e-06	6.93e-05	CcSEcCtD
Tramadol—Vision blurred—Topiramate—epilepsy syndrome	8.1e-06	6.92e-05	CcSEcCtD
Tramadol—Skin disorder—Gabapentin—epilepsy syndrome	8.1e-06	6.92e-05	CcSEcCtD
Tramadol—Somnolence—Pregabalin—epilepsy syndrome	8.08e-06	6.91e-05	CcSEcCtD
Tramadol—Hyperhidrosis—Gabapentin—epilepsy syndrome	8.06e-06	6.89e-05	CcSEcCtD
Tramadol—Tremor—Topiramate—epilepsy syndrome	8.05e-06	6.88e-05	CcSEcCtD
Tramadol—Vomiting—Lamotrigine—epilepsy syndrome	8.05e-06	6.88e-05	CcSEcCtD
Tramadol—Urticaria—Valproic Acid—epilepsy syndrome	7.99e-06	6.83e-05	CcSEcCtD
Tramadol—Rash—Lamotrigine—epilepsy syndrome	7.98e-06	6.82e-05	CcSEcCtD
Tramadol—Ill-defined disorder—Topiramate—epilepsy syndrome	7.97e-06	6.81e-05	CcSEcCtD
Tramadol—Dermatitis—Lamotrigine—epilepsy syndrome	7.97e-06	6.81e-05	CcSEcCtD
Tramadol—Abdominal pain—Valproic Acid—epilepsy syndrome	7.95e-06	6.79e-05	CcSEcCtD
Tramadol—Body temperature increased—Valproic Acid—epilepsy syndrome	7.95e-06	6.79e-05	CcSEcCtD
Tramadol—Anorexia—Gabapentin—epilepsy syndrome	7.95e-06	6.79e-05	CcSEcCtD
Tramadol—Anaemia—Topiramate—epilepsy syndrome	7.94e-06	6.79e-05	CcSEcCtD
Tramadol—Headache—Lamotrigine—epilepsy syndrome	7.93e-06	6.78e-05	CcSEcCtD
Tramadol—Decreased appetite—Pregabalin—epilepsy syndrome	7.9e-06	6.75e-05	CcSEcCtD
Tramadol—Agitation—Topiramate—epilepsy syndrome	7.9e-06	6.75e-05	CcSEcCtD
Tramadol—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	7.85e-06	6.71e-05	CcSEcCtD
Tramadol—Fatigue—Pregabalin—epilepsy syndrome	7.84e-06	6.7e-05	CcSEcCtD
Tramadol—Hypotension—Gabapentin—epilepsy syndrome	7.79e-06	6.66e-05	CcSEcCtD
Tramadol—Nausea—Carbamazepine—epilepsy syndrome	7.78e-06	6.65e-05	CcSEcCtD
Tramadol—Constipation—Pregabalin—epilepsy syndrome	7.77e-06	6.64e-05	CcSEcCtD
Tramadol—Pain—Pregabalin—epilepsy syndrome	7.77e-06	6.64e-05	CcSEcCtD
Tramadol—Malaise—Topiramate—epilepsy syndrome	7.75e-06	6.62e-05	CcSEcCtD
Tramadol—Vertigo—Topiramate—epilepsy syndrome	7.72e-06	6.6e-05	CcSEcCtD
Tramadol—Syncope—Topiramate—epilepsy syndrome	7.71e-06	6.59e-05	CcSEcCtD
Tramadol—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	7.59e-06	6.49e-05	CcSEcCtD
Tramadol—Palpitations—Topiramate—epilepsy syndrome	7.59e-06	6.49e-05	CcSEcCtD
Tramadol—Loss of consciousness—Topiramate—epilepsy syndrome	7.55e-06	6.45e-05	CcSEcCtD
Tramadol—Insomnia—Gabapentin—epilepsy syndrome	7.54e-06	6.44e-05	CcSEcCtD
Tramadol—Nausea—Lamotrigine—epilepsy syndrome	7.52e-06	6.42e-05	CcSEcCtD
Tramadol—Cough—Topiramate—epilepsy syndrome	7.5e-06	6.41e-05	CcSEcCtD
Tramadol—Feeling abnormal—Pregabalin—epilepsy syndrome	7.49e-06	6.4e-05	CcSEcCtD
Tramadol—Paraesthesia—Gabapentin—epilepsy syndrome	7.48e-06	6.4e-05	CcSEcCtD
Tramadol—Convulsion—Topiramate—epilepsy syndrome	7.44e-06	6.36e-05	CcSEcCtD
Tramadol—Gastrointestinal pain—Pregabalin—epilepsy syndrome	7.43e-06	6.35e-05	CcSEcCtD
Tramadol—Dyspnoea—Gabapentin—epilepsy syndrome	7.43e-06	6.35e-05	CcSEcCtD
Tramadol—Hypertension—Topiramate—epilepsy syndrome	7.42e-06	6.34e-05	CcSEcCtD
Tramadol—Somnolence—Gabapentin—epilepsy syndrome	7.41e-06	6.33e-05	CcSEcCtD
Tramadol—Hypersensitivity—Valproic Acid—epilepsy syndrome	7.41e-06	6.33e-05	CcSEcCtD
Tramadol—Dyspepsia—Gabapentin—epilepsy syndrome	7.34e-06	6.27e-05	CcSEcCtD
Tramadol—Chest pain—Topiramate—epilepsy syndrome	7.32e-06	6.25e-05	CcSEcCtD
Tramadol—Arthralgia—Topiramate—epilepsy syndrome	7.32e-06	6.25e-05	CcSEcCtD
Tramadol—Myalgia—Topiramate—epilepsy syndrome	7.32e-06	6.25e-05	CcSEcCtD
Tramadol—Anxiety—Topiramate—epilepsy syndrome	7.29e-06	6.23e-05	CcSEcCtD
Tramadol—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	7.26e-06	6.21e-05	CcSEcCtD
Tramadol—Decreased appetite—Gabapentin—epilepsy syndrome	7.25e-06	6.19e-05	CcSEcCtD
Tramadol—Discomfort—Topiramate—epilepsy syndrome	7.23e-06	6.18e-05	CcSEcCtD
Tramadol—Urticaria—Pregabalin—epilepsy syndrome	7.22e-06	6.17e-05	CcSEcCtD
Tramadol—Asthenia—Valproic Acid—epilepsy syndrome	7.21e-06	6.17e-05	CcSEcCtD
Tramadol—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	7.2e-06	6.15e-05	CcSEcCtD
Tramadol—Fatigue—Gabapentin—epilepsy syndrome	7.19e-06	6.14e-05	CcSEcCtD
Tramadol—Abdominal pain—Pregabalin—epilepsy syndrome	7.19e-06	6.14e-05	CcSEcCtD
Tramadol—Body temperature increased—Pregabalin—epilepsy syndrome	7.19e-06	6.14e-05	CcSEcCtD
Tramadol—Dry mouth—Topiramate—epilepsy syndrome	7.15e-06	6.11e-05	CcSEcCtD
Tramadol—Constipation—Gabapentin—epilepsy syndrome	7.13e-06	6.09e-05	CcSEcCtD
Tramadol—Pain—Gabapentin—epilepsy syndrome	7.13e-06	6.09e-05	CcSEcCtD
Tramadol—Pruritus—Valproic Acid—epilepsy syndrome	7.11e-06	6.08e-05	CcSEcCtD
Tramadol—Confusional state—Topiramate—epilepsy syndrome	7.07e-06	6.04e-05	CcSEcCtD
Tramadol—Infection—Topiramate—epilepsy syndrome	6.97e-06	5.95e-05	CcSEcCtD
Tramadol—Shock—Topiramate—epilepsy syndrome	6.9e-06	5.9e-05	CcSEcCtD
Tramadol—Diarrhoea—Valproic Acid—epilepsy syndrome	6.88e-06	5.88e-05	CcSEcCtD
Tramadol—Nervous system disorder—Topiramate—epilepsy syndrome	6.88e-06	5.88e-05	CcSEcCtD
Tramadol—Feeling abnormal—Gabapentin—epilepsy syndrome	6.87e-06	5.87e-05	CcSEcCtD
Tramadol—Thrombocytopenia—Topiramate—epilepsy syndrome	6.87e-06	5.87e-05	CcSEcCtD
Tramadol—Tachycardia—Topiramate—epilepsy syndrome	6.84e-06	5.85e-05	CcSEcCtD
Tramadol—Gastrointestinal pain—Gabapentin—epilepsy syndrome	6.82e-06	5.83e-05	CcSEcCtD
Tramadol—Skin disorder—Topiramate—epilepsy syndrome	6.81e-06	5.82e-05	CcSEcCtD
Tramadol—Hyperhidrosis—Topiramate—epilepsy syndrome	6.78e-06	5.79e-05	CcSEcCtD
Tramadol—Hypersensitivity—Pregabalin—epilepsy syndrome	6.7e-06	5.72e-05	CcSEcCtD
Tramadol—Anorexia—Topiramate—epilepsy syndrome	6.68e-06	5.71e-05	CcSEcCtD
Tramadol—Dizziness—Valproic Acid—epilepsy syndrome	6.65e-06	5.68e-05	CcSEcCtD
Tramadol—Urticaria—Gabapentin—epilepsy syndrome	6.62e-06	5.66e-05	CcSEcCtD
Tramadol—Abdominal pain—Gabapentin—epilepsy syndrome	6.59e-06	5.63e-05	CcSEcCtD
Tramadol—Body temperature increased—Gabapentin—epilepsy syndrome	6.59e-06	5.63e-05	CcSEcCtD
Tramadol—Hypotension—Topiramate—epilepsy syndrome	6.55e-06	5.6e-05	CcSEcCtD
Tramadol—Asthenia—Pregabalin—epilepsy syndrome	6.52e-06	5.57e-05	CcSEcCtD
Tramadol—Pruritus—Pregabalin—epilepsy syndrome	6.43e-06	5.5e-05	CcSEcCtD
Tramadol—Vomiting—Valproic Acid—epilepsy syndrome	6.39e-06	5.46e-05	CcSEcCtD
Tramadol—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	6.39e-06	5.46e-05	CcSEcCtD
Tramadol—Insomnia—Topiramate—epilepsy syndrome	6.34e-06	5.42e-05	CcSEcCtD
Tramadol—Rash—Valproic Acid—epilepsy syndrome	6.34e-06	5.42e-05	CcSEcCtD
Tramadol—Dermatitis—Valproic Acid—epilepsy syndrome	6.33e-06	5.41e-05	CcSEcCtD
Tramadol—Headache—Valproic Acid—epilepsy syndrome	6.3e-06	5.38e-05	CcSEcCtD
Tramadol—Paraesthesia—Topiramate—epilepsy syndrome	6.3e-06	5.38e-05	CcSEcCtD
Tramadol—Dyspnoea—Topiramate—epilepsy syndrome	6.25e-06	5.34e-05	CcSEcCtD
Tramadol—Somnolence—Topiramate—epilepsy syndrome	6.23e-06	5.33e-05	CcSEcCtD
Tramadol—Diarrhoea—Pregabalin—epilepsy syndrome	6.22e-06	5.32e-05	CcSEcCtD
Tramadol—Dyspepsia—Topiramate—epilepsy syndrome	6.17e-06	5.28e-05	CcSEcCtD
Tramadol—Hypersensitivity—Gabapentin—epilepsy syndrome	6.14e-06	5.25e-05	CcSEcCtD
Tramadol—Decreased appetite—Topiramate—epilepsy syndrome	6.1e-06	5.21e-05	CcSEcCtD
Tramadol—Gastrointestinal disorder—Topiramate—epilepsy syndrome	6.05e-06	5.17e-05	CcSEcCtD
Tramadol—Fatigue—Topiramate—epilepsy syndrome	6.05e-06	5.17e-05	CcSEcCtD
Tramadol—Dizziness—Pregabalin—epilepsy syndrome	6.01e-06	5.14e-05	CcSEcCtD
Tramadol—Pain—Topiramate—epilepsy syndrome	6e-06	5.13e-05	CcSEcCtD
Tramadol—Constipation—Topiramate—epilepsy syndrome	6e-06	5.13e-05	CcSEcCtD
Tramadol—Asthenia—Gabapentin—epilepsy syndrome	5.98e-06	5.11e-05	CcSEcCtD
Tramadol—Nausea—Valproic Acid—epilepsy syndrome	5.97e-06	5.1e-05	CcSEcCtD
Tramadol—Pruritus—Gabapentin—epilepsy syndrome	5.9e-06	5.04e-05	CcSEcCtD
Tramadol—Vomiting—Pregabalin—epilepsy syndrome	5.78e-06	4.94e-05	CcSEcCtD
Tramadol—Feeling abnormal—Topiramate—epilepsy syndrome	5.78e-06	4.94e-05	CcSEcCtD
Tramadol—Gastrointestinal pain—Topiramate—epilepsy syndrome	5.73e-06	4.9e-05	CcSEcCtD
Tramadol—Rash—Pregabalin—epilepsy syndrome	5.73e-06	4.9e-05	CcSEcCtD
Tramadol—Dermatitis—Pregabalin—epilepsy syndrome	5.73e-06	4.89e-05	CcSEcCtD
Tramadol—Diarrhoea—Gabapentin—epilepsy syndrome	5.7e-06	4.87e-05	CcSEcCtD
Tramadol—Headache—Pregabalin—epilepsy syndrome	5.69e-06	4.87e-05	CcSEcCtD
Tramadol—Urticaria—Topiramate—epilepsy syndrome	5.57e-06	4.76e-05	CcSEcCtD
Tramadol—Abdominal pain—Topiramate—epilepsy syndrome	5.54e-06	4.74e-05	CcSEcCtD
Tramadol—Body temperature increased—Topiramate—epilepsy syndrome	5.54e-06	4.74e-05	CcSEcCtD
Tramadol—Dizziness—Gabapentin—epilepsy syndrome	5.51e-06	4.71e-05	CcSEcCtD
Tramadol—Nausea—Pregabalin—epilepsy syndrome	5.4e-06	4.61e-05	CcSEcCtD
Tramadol—Vomiting—Gabapentin—epilepsy syndrome	5.3e-06	4.53e-05	CcSEcCtD
Tramadol—Rash—Gabapentin—epilepsy syndrome	5.26e-06	4.49e-05	CcSEcCtD
Tramadol—Dermatitis—Gabapentin—epilepsy syndrome	5.25e-06	4.49e-05	CcSEcCtD
Tramadol—Headache—Gabapentin—epilepsy syndrome	5.22e-06	4.46e-05	CcSEcCtD
Tramadol—Hypersensitivity—Topiramate—epilepsy syndrome	5.17e-06	4.42e-05	CcSEcCtD
Tramadol—Asthenia—Topiramate—epilepsy syndrome	5.03e-06	4.3e-05	CcSEcCtD
Tramadol—Pruritus—Topiramate—epilepsy syndrome	4.96e-06	4.24e-05	CcSEcCtD
Tramadol—Nausea—Gabapentin—epilepsy syndrome	4.95e-06	4.23e-05	CcSEcCtD
Tramadol—Diarrhoea—Topiramate—epilepsy syndrome	4.8e-06	4.1e-05	CcSEcCtD
Tramadol—Dizziness—Topiramate—epilepsy syndrome	4.64e-06	3.96e-05	CcSEcCtD
Tramadol—Vomiting—Topiramate—epilepsy syndrome	4.46e-06	3.81e-05	CcSEcCtD
Tramadol—Rash—Topiramate—epilepsy syndrome	4.42e-06	3.78e-05	CcSEcCtD
Tramadol—Dermatitis—Topiramate—epilepsy syndrome	4.42e-06	3.78e-05	CcSEcCtD
Tramadol—Headache—Topiramate—epilepsy syndrome	4.39e-06	3.75e-05	CcSEcCtD
Tramadol—Nausea—Topiramate—epilepsy syndrome	4.17e-06	3.56e-05	CcSEcCtD
Tramadol—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	2.47e-06	5.5e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—IL6ST—epilepsy syndrome	2.47e-06	5.5e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—YWHAZ—epilepsy syndrome	2.44e-06	5.44e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—JUNB—epilepsy syndrome	2.44e-06	5.44e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CNR1—epilepsy syndrome	2.44e-06	5.44e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—S100B—epilepsy syndrome	2.44e-06	5.44e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—APOE—epilepsy syndrome	2.44e-06	5.43e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—PLCB1—epilepsy syndrome	2.43e-06	5.42e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—HTR2A—epilepsy syndrome	2.43e-06	5.42e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—SOCS3—epilepsy syndrome	2.42e-06	5.39e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—NGF—epilepsy syndrome	2.42e-06	5.38e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—CDC42—epilepsy syndrome	2.41e-06	5.37e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—CYP2D6—epilepsy syndrome	2.41e-06	5.37e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—KDR—epilepsy syndrome	2.39e-06	5.32e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	2.38e-06	5.31e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—GBE1—epilepsy syndrome	2.38e-06	5.31e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—HTR7—epilepsy syndrome	2.38e-06	5.31e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—CHRM3—epilepsy syndrome	2.35e-06	5.24e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—KCNJ11—epilepsy syndrome	2.35e-06	5.24e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—CCR5—epilepsy syndrome	2.35e-06	5.24e-05	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—PRKCB—epilepsy syndrome	2.35e-06	5.23e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—TSC1—epilepsy syndrome	2.34e-06	5.22e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—PTK2B—epilepsy syndrome	2.34e-06	5.22e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—AVP—epilepsy syndrome	2.34e-06	5.2e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—HBEGF—epilepsy syndrome	2.31e-06	5.15e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—AGT—epilepsy syndrome	2.31e-06	5.14e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—HTR2A—epilepsy syndrome	2.3e-06	5.12e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—PRKCB—epilepsy syndrome	2.3e-06	5.12e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—ADRA2A—epilepsy syndrome	2.29e-06	5.11e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—IL6ST—epilepsy syndrome	2.29e-06	5.1e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—BCHE—epilepsy syndrome	2.28e-06	5.09e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—NTRK2—epilepsy syndrome	2.28e-06	5.08e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—SST—epilepsy syndrome	2.28e-06	5.08e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CCR2—epilepsy syndrome	2.28e-06	5.08e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—AKT3—epilepsy syndrome	2.27e-06	5.06e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—DUSP6—epilepsy syndrome	2.26e-06	5.03e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—POMC—epilepsy syndrome	2.26e-06	5.03e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	2.24e-06	5e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—ADRA2A—epilepsy syndrome	2.23e-06	4.97e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—PLAT—epilepsy syndrome	2.22e-06	4.95e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—ADAM10—epilepsy syndrome	2.22e-06	4.94e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—HES1—epilepsy syndrome	2.21e-06	4.92e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—CCL2—epilepsy syndrome	2.21e-06	4.92e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—TSC2—epilepsy syndrome	2.18e-06	4.87e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—AGT—epilepsy syndrome	2.18e-06	4.86e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	2.18e-06	4.86e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—SLC2A1—epilepsy syndrome	2.18e-06	4.86e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—PLCB1—epilepsy syndrome	2.16e-06	4.8e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—TH—epilepsy syndrome	2.15e-06	4.79e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—FYN—epilepsy syndrome	2.15e-06	4.78e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—BDKRB2—epilepsy syndrome	2.14e-06	4.77e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CXCL12—epilepsy syndrome	2.14e-06	4.77e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—H2AFX—epilepsy syndrome	2.14e-06	4.77e-05	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—POMC—epilepsy syndrome	2.14e-06	4.77e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—APOE—epilepsy syndrome	2.14e-06	4.76e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—MEF2C—epilepsy syndrome	2.14e-06	4.76e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—PRKCB—epilepsy syndrome	2.13e-06	4.75e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—ALAD—epilepsy syndrome	2.13e-06	4.74e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—NT5E—epilepsy syndrome	2.13e-06	4.74e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—IL6ST—epilepsy syndrome	2.12e-06	4.73e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—JUNB—epilepsy syndrome	2.1e-06	4.68e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CNR1—epilepsy syndrome	2.1e-06	4.68e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—S100B—epilepsy syndrome	2.1e-06	4.67e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—PLCB1—epilepsy syndrome	2.09e-06	4.67e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—POMC—epilepsy syndrome	2.09e-06	4.67e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—KDR—epilepsy syndrome	2.09e-06	4.67e-05	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—HMOX1—epilepsy syndrome	2.08e-06	4.64e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—SOCS3—epilepsy syndrome	2.08e-06	4.63e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CDC42—epilepsy syndrome	2.07e-06	4.62e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—YWHAZ—epilepsy syndrome	2.06e-06	4.6e-05	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—CAT—epilepsy syndrome	2.06e-06	4.58e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—HTR7—epilepsy syndrome	2.05e-06	4.57e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—CCL2—epilepsy syndrome	2.05e-06	4.57e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—NGF—epilepsy syndrome	2.04e-06	4.55e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	2.03e-06	4.52e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	2.03e-06	4.52e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—PRKCB—epilepsy syndrome	2.02e-06	4.49e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—IL6ST—epilepsy syndrome	2.01e-06	4.47e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—AVP—epilepsy syndrome	2.01e-06	4.47e-05	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—ABCB1—epilepsy syndrome	2e-06	4.46e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—HBEGF—epilepsy syndrome	1.99e-06	4.44e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—CCR5—epilepsy syndrome	1.99e-06	4.42e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	1.98e-06	4.42e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—AKT3—epilepsy syndrome	1.95e-06	4.36e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—ADSL—epilepsy syndrome	1.94e-06	4.33e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—HTR2A—epilepsy syndrome	1.94e-06	4.33e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—POMC—epilepsy syndrome	1.94e-06	4.33e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—ABCG2—epilepsy syndrome	1.92e-06	4.27e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—ADAM10—epilepsy syndrome	1.91e-06	4.25e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—GLUL—epilepsy syndrome	1.91e-06	4.25e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—CCL2—epilepsy syndrome	1.9e-06	4.23e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—HES1—epilepsy syndrome	1.9e-06	4.23e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	1.87e-06	4.17e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—CYP2C19—epilepsy syndrome	1.87e-06	4.16e-05	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—GPX1—epilepsy syndrome	1.86e-06	4.14e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—CYP11A1—epilepsy syndrome	1.86e-06	4.13e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—FGF2—epilepsy syndrome	1.85e-06	4.13e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—TSC2—epilepsy syndrome	1.85e-06	4.11e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—FYN—epilepsy syndrome	1.84e-06	4.11e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—AGT—epilepsy syndrome	1.84e-06	4.11e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—H2AFX—epilepsy syndrome	1.84e-06	4.09e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—POMC—epilepsy syndrome	1.84e-06	4.09e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—MEF2C—epilepsy syndrome	1.83e-06	4.09e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—APOE—epilepsy syndrome	1.81e-06	4.03e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—S100B—epilepsy syndrome	1.81e-06	4.02e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—CCL2—epilepsy syndrome	1.8e-06	4e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—HMOX1—epilepsy syndrome	1.79e-06	3.99e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—SOCS3—epilepsy syndrome	1.79e-06	3.98e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CDC42—epilepsy syndrome	1.78e-06	3.97e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—YWHAZ—epilepsy syndrome	1.77e-06	3.95e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—KDR—epilepsy syndrome	1.77e-06	3.94e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—CAT—epilepsy syndrome	1.77e-06	3.94e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—NGF—epilepsy syndrome	1.75e-06	3.91e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	1.75e-06	3.9e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—AVP—epilepsy syndrome	1.73e-06	3.85e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—ABCB1—epilepsy syndrome	1.72e-06	3.83e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—RELA—epilepsy syndrome	1.72e-06	3.83e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CCR5—epilepsy syndrome	1.71e-06	3.8e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—PRKCB—epilepsy syndrome	1.7e-06	3.8e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—AQP1—epilepsy syndrome	1.7e-06	3.79e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—IL6ST—epilepsy syndrome	1.7e-06	3.78e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—MTOR—epilepsy syndrome	1.69e-06	3.76e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—HTR2A—epilepsy syndrome	1.67e-06	3.72e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—HES1—epilepsy syndrome	1.63e-06	3.64e-05	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—AGT—epilepsy syndrome	1.63e-06	3.63e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—FGF2—epilepsy syndrome	1.62e-06	3.62e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—GPX1—epilepsy syndrome	1.6e-06	3.56e-05	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—APOE—epilepsy syndrome	1.6e-06	3.56e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—ADRA2A—epilepsy syndrome	1.59e-06	3.55e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—FYN—epilepsy syndrome	1.59e-06	3.54e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—BCHE—epilepsy syndrome	1.59e-06	3.54e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—TSC2—epilepsy syndrome	1.59e-06	3.53e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—AGT—epilepsy syndrome	1.58e-06	3.53e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—H2AFX—epilepsy syndrome	1.58e-06	3.53e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—MEF2C—epilepsy syndrome	1.58e-06	3.52e-05	CbGpPWpGaD
Tramadol—OPRD1—GPCR downstream signaling—AKT1—epilepsy syndrome	1.56e-06	3.49e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—POMC—epilepsy syndrome	1.55e-06	3.46e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—APOE—epilepsy syndrome	1.55e-06	3.46e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—CASP3—epilepsy syndrome	1.55e-06	3.45e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	1.54e-06	3.42e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	1.54e-06	3.42e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—YWHAZ—epilepsy syndrome	1.53e-06	3.4e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—KDR—epilepsy syndrome	1.52e-06	3.39e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—CCL2—epilepsy syndrome	1.52e-06	3.38e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	1.51e-06	3.37e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—NGF—epilepsy syndrome	1.51e-06	3.36e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—RELA—epilepsy syndrome	1.51e-06	3.36e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—JUN—epilepsy syndrome	1.51e-06	3.36e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	1.5e-06	3.34e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—TH—epilepsy syndrome	1.49e-06	3.33e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—MTOR—epilepsy syndrome	1.48e-06	3.29e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CCR5—epilepsy syndrome	1.47e-06	3.27e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—MMP9—epilepsy syndrome	1.47e-06	3.26e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—PRKCB—epilepsy syndrome	1.46e-06	3.26e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—IL6ST—epilepsy syndrome	1.46e-06	3.25e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—HTR2A—epilepsy syndrome	1.44e-06	3.2e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—AKT1—epilepsy syndrome	1.42e-06	3.17e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—AGT—epilepsy syndrome	1.4e-06	3.13e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—APOE—epilepsy syndrome	1.37e-06	3.06e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—FGF2—epilepsy syndrome	1.37e-06	3.06e-05	CbGpPWpGaD
Tramadol—OPRK1—GPCR downstream signaling—AKT1—epilepsy syndrome	1.37e-06	3.06e-05	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—POMC—epilepsy syndrome	1.37e-06	3.06e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—TSC2—epilepsy syndrome	1.36e-06	3.04e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—AGT—epilepsy syndrome	1.36e-06	3.04e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—CASP3—epilepsy syndrome	1.36e-06	3.03e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—SRC—epilepsy syndrome	1.35e-06	3.01e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—APOE—epilepsy syndrome	1.34e-06	2.98e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—POMC—epilepsy syndrome	1.33e-06	2.97e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—JUN—epilepsy syndrome	1.32e-06	2.94e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—VEGFA—epilepsy syndrome	1.32e-06	2.93e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—KDR—epilepsy syndrome	1.31e-06	2.92e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CCL2—epilepsy syndrome	1.3e-06	2.91e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—MMP9—epilepsy syndrome	1.28e-06	2.86e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—RELA—epilepsy syndrome	1.27e-06	2.84e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—PRKCB—epilepsy syndrome	1.26e-06	2.81e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—IL6ST—epilepsy syndrome	1.25e-06	2.8e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	1.25e-06	2.79e-05	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—ALB—epilepsy syndrome	1.25e-06	2.79e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—MTOR—epilepsy syndrome	1.25e-06	2.78e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—AKT1—epilepsy syndrome	1.25e-06	2.78e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	1.25e-06	2.78e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—CAT—epilepsy syndrome	1.23e-06	2.74e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	1.22e-06	2.72e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	1.21e-06	2.7e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	1.2e-06	2.66e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—SRC—epilepsy syndrome	1.18e-06	2.64e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—POMC—epilepsy syndrome	1.18e-06	2.63e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—FGF2—epilepsy syndrome	1.18e-06	2.63e-05	CbGpPWpGaD
Tramadol—OPRM1—GPCR downstream signaling—AKT1—epilepsy syndrome	1.16e-06	2.58e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—VEGFA—epilepsy syndrome	1.15e-06	2.57e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—CASP3—epilepsy syndrome	1.15e-06	2.56e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—POMC—epilepsy syndrome	1.15e-06	2.56e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CCL2—epilepsy syndrome	1.12e-06	2.5e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—JUN—epilepsy syndrome	1.12e-06	2.49e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—GPX1—epilepsy syndrome	1.11e-06	2.48e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	1.09e-06	2.44e-05	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—PTGS2—epilepsy syndrome	1.09e-06	2.44e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—RELA—epilepsy syndrome	1.09e-06	2.44e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—MMP9—epilepsy syndrome	1.09e-06	2.42e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—ALB—epilepsy syndrome	1.08e-06	2.4e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—MTOR—epilepsy syndrome	1.07e-06	2.39e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—AKT1—epilepsy syndrome	1.05e-06	2.35e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	1.04e-06	2.32e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—BCHE—epilepsy syndrome	1.04e-06	2.31e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—FGF2—epilepsy syndrome	1.01e-06	2.26e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—SRC—epilepsy syndrome	1e-06	2.23e-05	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—AKT1—epilepsy syndrome	9.96e-07	2.22e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	9.9e-07	2.21e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CASP3—epilepsy syndrome	9.87e-07	2.2e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	9.79e-07	2.18e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—TH—epilepsy syndrome	9.76e-07	2.17e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—VEGFA—epilepsy syndrome	9.75e-07	2.17e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—AGT—epilepsy syndrome	9.75e-07	2.17e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—JUN—epilepsy syndrome	9.58e-07	2.14e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—APOE—epilepsy syndrome	9.55e-07	2.13e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—RELA—epilepsy syndrome	9.42e-07	2.1e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—PTGS2—epilepsy syndrome	9.42e-07	2.1e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—MMP9—epilepsy syndrome	9.32e-07	2.08e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—MTOR—epilepsy syndrome	9.24e-07	2.06e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—AKT1—epilepsy syndrome	9.04e-07	2.02e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—SRC—epilepsy syndrome	8.6e-07	1.92e-05	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—AKT1—epilepsy syndrome	8.57e-07	1.91e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CASP3—epilepsy syndrome	8.5e-07	1.89e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—AKT1—epilepsy syndrome	8.39e-07	1.87e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—VEGFA—epilepsy syndrome	8.37e-07	1.87e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—JUN—epilepsy syndrome	8.25e-07	1.84e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—POMC—epilepsy syndrome	8.2e-07	1.83e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	8.15e-07	1.81e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—CAT—epilepsy syndrome	8.04e-07	1.79e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—MMP9—epilepsy syndrome	8.03e-07	1.79e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	7.82e-07	1.74e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—AKT1—epilepsy syndrome	7.79e-07	1.73e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—ALB—epilepsy syndrome	7.48e-07	1.67e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—SRC—epilepsy syndrome	7.4e-07	1.65e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—AKT1—epilepsy syndrome	7.36e-07	1.64e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—GPX1—epilepsy syndrome	7.27e-07	1.62e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—VEGFA—epilepsy syndrome	7.21e-07	1.61e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	6.54e-07	1.46e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—AGT—epilepsy syndrome	6.37e-07	1.42e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—APOE—epilepsy syndrome	6.24e-07	1.39e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—AKT1—epilepsy syndrome	6.22e-07	1.39e-05	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—AKT1—epilepsy syndrome	5.5e-07	1.23e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—POMC—epilepsy syndrome	5.36e-07	1.2e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—AKT1—epilepsy syndrome	5.34e-07	1.19e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—ALB—epilepsy syndrome	4.89e-07	1.09e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—AKT1—epilepsy syndrome	4.73e-07	1.05e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—AKT1—epilepsy syndrome	4.6e-07	1.02e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	4.28e-07	9.53e-06	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—AKT1—epilepsy syndrome	3.29e-07	7.33e-06	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—AKT1—epilepsy syndrome	2.15e-07	4.79e-06	CbGpPWpGaD
